Cell-based and gene therapy products are growing and becoming a major component of the biotechnology industry. A recent initiative funded by NIIMBL brought together a collaborative of six partner institutions and their regional CGT industry partners. The goals of the WEBET project, or Workforce Expansion in Biomanufacturing Emerging Technologies, is to reseacrh the workforce needs of the sector, identify the technical skills and knowledge needed to develop, manufacture, and test these advanced therapies and finally to create hands-on curriculum that will produce well trained graduates ready to join this important biotechnology sector.
On December 3, 2021, and January 24, 2022, InnovATEBio hosted WEBET Train-the-Trainer Webinars- view presentations here:
CELL AND GENE THERAPY TRAIN THE TRAINER WEBINAR 1 (Recorded December 3, 2021) Presentations include: CGT labor market research outcomes, technical skill standards for CGT technicians, course requirements, and newly developed lab-based curriculum on AAV production in HEK 293 cells.
CELL AND GENE THERAPY TRAIN THE TRAINER WEBINAR 2 ( Recorded January 24, 2022) Presentations include: Skill Standards and Curriculum for Training Cell and Gene Therapy Technicians, Regulatory Considerations for CGT, CGT Analytics, and newly developed lab-based curriculum on AAV production analytics and AAV transduction evalutation by flow cytometry, immunofluorescence and western blot.
Download Labor Market Report Here:
Prepared for NIIMBL Project 2.2-152 WEBET: Workforce Expansion in Biomanufacturing Emerging Technologies
Upstream and Downstream Processing Coming soon.....
Quality Control SOP: viral gene delivery and evaluation using flow cytometry
Equipment Required for Training Cell and Gene Therapy Technicians
AAV Vector Manufacturing: Challenges and Opportunities
Please register for an account first. If you already have one, log in here.